Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (141-150 of 953) with videos related to

Pageof 96
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 27, 2021
Routine magnetoencephalography in memory clinic patients: A machine learning approachAlida A Gouw, Arjan Hillebrand, Deborah N Schoonhoven, et al.
Age and Ageing|March 14, 2007
Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitusBarbera van Harten, Joukje Oosterman, Dino Muslimovic, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypesYolande A L Pijnenburg, Nicolaas A Verwey, Wiesje M van der Flier, et al.
Neurobiology of Aging|April 9, 2013
Different patterns of gray matter atrophy in early- and late-onset Alzheimer's diseaseChristiane Möller, Hugo Vrenken, Lize Jiskoot, et al.
Neurobiology of Aging|April 14, 2018
EEG-based neurophysiological indicators of hallucinations in Alzheimer's disease: Comparison with dementia with Lewy bodiesMeenakshi Dauwan, Mascha M J Linszen, Afina W Lemstra, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's DiseaseArgonde C van Harten, Joyce Mulders, Philip Scheltens, et al.
Neurobiology of Aging|June 3, 2017
CSF ApoE predicts clinical progression in nondemented APOEε4 carriersArgonde C van Harten, Wesley Jongbloed, Charlotte E Teunissen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
CSF proteomic signature predicts progression to Alzheimer's disease dementiaEleonora M Vromen, Marta Del Campo Milán, Philip Scheltens, et al.
Neuropsychiatric Disease and Treatment|May 2, 2017
Psychosis in behavioral variant frontotemporal dementiaFlora T Gossink, Everard Gb Vijverberg, Welmoed Krudop, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2018
Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's DiseaseCharlotte E Teunissen, Ming-Jang Chiu, Che-Chuan Yang, et al.
Pageof 96

Showing results (141-150 of 953) with videos related to

Sort By:
Pageof 96
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 27, 2021
Routine magnetoencephalography in memory clinic patients: A machine learning approachAlida A Gouw, Arjan Hillebrand, Deborah N Schoonhoven, et al.
Age and Ageing|March 14, 2007
Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitusBarbera van Harten, Joukje Oosterman, Dino Muslimovic, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypesYolande A L Pijnenburg, Nicolaas A Verwey, Wiesje M van der Flier, et al.
Neurobiology of Aging|April 9, 2013
Different patterns of gray matter atrophy in early- and late-onset Alzheimer's diseaseChristiane Möller, Hugo Vrenken, Lize Jiskoot, et al.
Neurobiology of Aging|April 14, 2018
EEG-based neurophysiological indicators of hallucinations in Alzheimer's disease: Comparison with dementia with Lewy bodiesMeenakshi Dauwan, Mascha M J Linszen, Afina W Lemstra, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's DiseaseArgonde C van Harten, Joyce Mulders, Philip Scheltens, et al.
Neurobiology of Aging|June 3, 2017
CSF ApoE predicts clinical progression in nondemented APOEε4 carriersArgonde C van Harten, Wesley Jongbloed, Charlotte E Teunissen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
CSF proteomic signature predicts progression to Alzheimer's disease dementiaEleonora M Vromen, Marta Del Campo Milán, Philip Scheltens, et al.
Neuropsychiatric Disease and Treatment|May 2, 2017
Psychosis in behavioral variant frontotemporal dementiaFlora T Gossink, Everard Gb Vijverberg, Welmoed Krudop, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2018
Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's DiseaseCharlotte E Teunissen, Ming-Jang Chiu, Che-Chuan Yang, et al.
Pageof 96